The open reading frame (ORF) coding for yeast cytoplasmic L-asparaginase ScASNaseI (UniProt P38986, gene ASP1) consisting of 1143 bp, was amplified with PCR using as template genomic DNA from the Saccharomyces cerevisiae S288C wildtype strain. NdeI and BamHI sites were incorporated at the 5'-and 3'-oligonucleotides' ends, respectively: 5'-oligo GGAATTCCATATGAAAAGCGATTCAGTTGAAATC; 3'-oligo CGCGGATCCTCACCCACCATAGACGCCAGTG. The PCR reaction mixture consisted of oligonucleotide mix, KAPA high fidelity buffer, dNTPs and KAPA HiFi DNA polymerase. The reaction was initiated at 95 C for 3 min, followed by 25 cycles of denaturation at 98 C for 20 s, primer annealing at 60 C for 30 s, and extension at 72 C for 30 s. The amplification reaction was terminated after a 5 min polishing step at 72 C. The PCR product ( Figure S1 ) was gel-purified, digested with NdeI and BamHI H.F., purified with PCR clean-up kit and then ligated overnight at 16 C into pET14b-SUMO vector ( Figure S2 ) using T4 DNA ligase. The
2 ligation mixture was used to transform DH5α E.coli cells. Positive clones were determined following colony PCR screening using one primer for the vector (Forward) and one primer for the insert (Reverse), restriction digestion with NdeI and BamHI H.F., and finally sequencing of the cloned DNA insert. The expressed protein construct includes an N-terminal 6-histidine tag, followed by the yeast SUMO (Small Ubiquitin MOdifier) tag which has proven to improve heterologous protein solubility and stability.
E.coli BL21(DE3) C41 cells containing the ScASNaseI-encoding plasmid were cultured overnight at 37 C in TB medium supplemented with 200 µg/ml ampicillin. A fraction of this culture was used to inoculate fresh TB culture (dilution 1:100) supplemented with 200 µg/ml ampicillin. When O.D.600 reached ~ 0.5-0.7, the expression was induced by adding IPTG to a final concentration of 1 mM. After incubation at 37 C for 8 h, the culture was centrifuged at 4,000g for 30 min, the cells were harvested, resuspended in affinity matrix binding buffer (50 mM Na 2 HPO 4 , 0.5 M NaCl, 10 mM imidazole, pH 8.0), and ultimately lysed by sonication. The cell lysate was centrifuged at 17,200g for 45 min, the resulting supernatant mixed with preequilibrated nickel agarose beads, and incubated at 4 C for 3 h under rotation. Subsequently, the mixture was filled in a 5 mL polypropylene column and dried by gravity. The nickel resin was washed with 25 bed volumes of washing buffer (50 mM Na 2 HPO 4 , 1 M NaCl, 20 mM imidazole, pH 8.0). Finally, the bound protein was eluted from the column by applying 300 mM imidazole, and dropwise collection of fractions. All purification steps were performed at 4 C.
The collected fractions were mixed, and buffer was exchanged against 50 mM Na 2 HPO 4 , 0.5 NaCl, pH 7.5 using a PD-10 column (GE). The eluted protein fraction was incubated with yeast SUMO protease (molar ratio protease:protein ~ 1:100) at 30 C for 2 h in order to cleave the Nterminal His 6 -SUMO tag. In the last purification step, the protein was subjected to size exclusion 3 chromatography by passing it through a Superdex 200 column (Pharmacia/GE) to remove the cleaved tag. Protein purity was evaluated by SDS-PAGE and was estimated to exceed 95%. The protein sample was aliquoted, mixed with 25% glycerol, and stored at -20 C until use. The E.coli L-ASNase II (EcASNaseII) was expressed and purified analogously.
The fusion protein eGFP-ScASNaseI was constructed using a modified pET14b vector which was generated for the needs of the present study ( Figure S3 ). The N-terminus included the His 6 -eGFP part followed by a short hydrophilic flexible linker consisting of (Gly-Ser)2. Downstream of the His 6 -eGFP plus linker moiety, the coding region for ScASNaseI was inserted via NdeI and Figure   S10 , images of the untreated cells were taken just before the drugs were added (t=0), and treated cells were imaged after 72 h of incubation.
